BEXSERO Overview

BEXSERO is the only meningitis B (MenB) vaccine that combines 4 different components: fHbp, NadA, NHBA, and PorA P1.4, each of which targets a different mechanism involved in MenB survival and disease development.1-3

More than 99% of invasive MenB strains contain genes for at least 1 BEXSERO component.1

Explore the 4 Antigens >

Clinical Profile Header

BEXSERO offers demonstrated immune response

BEXSERO demonstrated serum bactericidal activity against 3 component strains prevalent among strains in the US.4,*

*Immune response data were recorded for antigens fHbp, NadA, and PorA P1.4. A suitable strain for assessing bactericidal activity of NHBA-specific antibodies was not available.4

Vaccination with BEXSERO may not provide protection against all meningococcal serogroup B strains.4

Vaccination may not protect all recipients.

fHbp=factor H binding protein; NadA=Neisserial adhesin A; NHBA=Neisserial Heparin Binding Antigen; PorA=Porin A P1.4 present in Outer Membrane Vesicles (OMV).